Tech Company Financing Transactions
Mythic Therapeutics Funding Round
Mythic Therapeutics closed a $103 million venture capital round on 12/17/2021. Investors included Viking Global Investors, First Round Capital and Foresite Capital.
Transaction Overview
Company Name
Announced On
12/17/2021
Transaction Type
Venture Equity
Amount
$103,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds from Mythic's Series B will finance the lead program through first-in-human clinical studies in lung cancer and fund pipeline development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Beaver St.
Waltham, MA 02453
USA
Waltham, MA 02453
USA
Phone
Undisclosed
Website
Email Address
Overview
At Mythic Therapeutics, we approach our work as entrepreneurs and innovators, blazing new trails that lead to better patient outcomes. We do so decisively and thoughtfully, drawing upon the decades of experience within our leadership team and scientific advisers. We are changing the state of the art.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alex Nichols
Browse more venture capital transactions:
Prev: 12/17/2021: Ilumed venture capital transaction
Next: 12/17/2021: Haystacks.AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs